Alembic Pharma Receives USFDA Approval for Prucalopride Tablets
MM Desk
31 July, 2026
Alembic Pharmaceuticals Limited has received final approval from the United States Food and Drug Administration
Alembic Pharmaceuticals Limited has received final approval from the United States Food and Drug Administration
Alembic Pharmaceuticals Limited (“Alembic”) today announced that its partner NATCO Pharma Limited (“NATCO”) has received
Alembic Pharmaceuticals Limited has received final approval from the United States Food and Drug Administration
Alembic Pharmaceuticals Limited has received tentative approval from the United States Food and Drug Administration
Alembic Pharmaceuticals Limited has secured final approval from the United States Food and Drug Administration
Alembic Pharmaceuticals Limited has received tentative approval from the United States Food and Drug Administration
Alembic Pharmaceuticals Limited has received final approval from the United States Food and Drug Administration
Alembic Pharmaceuticals Limited today announced that it has received final approval from the United States
Alembic Pharmaceuticals Limited has received tentative approval from the United States Food and Drug Administration
Alembic Pharmaceuticals Limited has announced that it has received final approval from the United States